And for patients facing extreme limitations to mobility, or who live vast distances from hospitals and clinics, mobile ...

An update from Bluejay Diagnostics ( ($BJDX) ) is now available. On December 29, 2025, Bluejay Diagnostics announced it had completed ...

Regeneron Pharmaceuticals ($REGN) announced an update on their ongoing clinical study. Study OverviewRegeneron Pharmaceuticals has launched a new ...

Researchers reveal structure of ancient viral protein appearing in breast cancer, lupus, and ALS, opening new paths for ...

Genmab is discontinuing development of acasunlimab after a pipeline review, pivoting focus to other oncology antibodies.

The North Texas Region of the Red Cross operates two fixed donation sites in the area: the Irving Blood and Platelet Donation ...

Next-generation biologics, such as bispecifics, fusion proteins, and multi-specifics, have multiple functionalities that ...

For the second year in a row, the US has surpassed 25,000 whooping cough cases — another sign of the risks of falling ...

See why TG Therapeutics, Inc. earns a Buy rating, with insights on Briumvi's efficacy and market growth in multiple sclerosis ...

Insights from ASH 2025, including anticipated presentations, key takeaways, and how emerging research in paroxysmal nocturnal ...

From robotic surgery performed 7,000 miles away to the first blood test to help diagnose Alzheimer’s disease, 2025 has been a ...

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that ...